Targeting vaccines to dendritic cells

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Targeting vaccines to dendritic cells. / Foged, Camilla; Sundblad, Anne; Hovgaard, Lars.

In: Pharmaceutical Research, Vol. 19, No. 3, 2002, p. 229-38.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Foged, C, Sundblad, A & Hovgaard, L 2002, 'Targeting vaccines to dendritic cells', Pharmaceutical Research, vol. 19, no. 3, pp. 229-38.

APA

Foged, C., Sundblad, A., & Hovgaard, L. (2002). Targeting vaccines to dendritic cells. Pharmaceutical Research, 19(3), 229-38.

Vancouver

Foged C, Sundblad A, Hovgaard L. Targeting vaccines to dendritic cells. Pharmaceutical Research. 2002;19(3):229-38.

Author

Foged, Camilla ; Sundblad, Anne ; Hovgaard, Lars. / Targeting vaccines to dendritic cells. In: Pharmaceutical Research. 2002 ; Vol. 19, No. 3. pp. 229-38.

Bibtex

@article{ba96b414f9704d99851f95167902664d,
title = "Targeting vaccines to dendritic cells",
abstract = "Dendritic cells (DC) are specialized antigen presenting cells (APC) with a remarkable ability to take up antigens and stimulate major histocompatibility complex (MHC)-restricted specific immune responses. Recent discoveries have shown that their role in initiating primary immune responses seems to be far superior to that of B-cells and macrophages. DC are localized at strategic places in the body at sites used by pathogens to enter the organism, and are thereby in an optimal position to capture antigens. In general, vaccination strategies try to mimic the invasiveness of the pathogens. DC are considered to play a central role for the provocation of primary immune responses by vaccination. A rational way of improving the potency and safety of new and already existing vaccines could therefore be to direct vaccines specifically to DC. There is a need for developing multifunctional vaccine drug delivery systems (DDS) with adjuvant effect that target DC directly and induce optimal immune responses. This paper will review the current knowledge of DC physiology as well as the progress in the field of novel vaccination strategies that directly or indirectly aim at targeting DC.",
author = "Camilla Foged and Anne Sundblad and Lars Hovgaard",
note = "Keywords: Animals; Dendritic Cells; Drug Delivery Systems; Humans; Vaccination; Vaccines",
year = "2002",
language = "English",
volume = "19",
pages = "229--38",
journal = "Pharmaceutical Research",
issn = "0724-8741",
publisher = "Springer",
number = "3",

}

RIS

TY - JOUR

T1 - Targeting vaccines to dendritic cells

AU - Foged, Camilla

AU - Sundblad, Anne

AU - Hovgaard, Lars

N1 - Keywords: Animals; Dendritic Cells; Drug Delivery Systems; Humans; Vaccination; Vaccines

PY - 2002

Y1 - 2002

N2 - Dendritic cells (DC) are specialized antigen presenting cells (APC) with a remarkable ability to take up antigens and stimulate major histocompatibility complex (MHC)-restricted specific immune responses. Recent discoveries have shown that their role in initiating primary immune responses seems to be far superior to that of B-cells and macrophages. DC are localized at strategic places in the body at sites used by pathogens to enter the organism, and are thereby in an optimal position to capture antigens. In general, vaccination strategies try to mimic the invasiveness of the pathogens. DC are considered to play a central role for the provocation of primary immune responses by vaccination. A rational way of improving the potency and safety of new and already existing vaccines could therefore be to direct vaccines specifically to DC. There is a need for developing multifunctional vaccine drug delivery systems (DDS) with adjuvant effect that target DC directly and induce optimal immune responses. This paper will review the current knowledge of DC physiology as well as the progress in the field of novel vaccination strategies that directly or indirectly aim at targeting DC.

AB - Dendritic cells (DC) are specialized antigen presenting cells (APC) with a remarkable ability to take up antigens and stimulate major histocompatibility complex (MHC)-restricted specific immune responses. Recent discoveries have shown that their role in initiating primary immune responses seems to be far superior to that of B-cells and macrophages. DC are localized at strategic places in the body at sites used by pathogens to enter the organism, and are thereby in an optimal position to capture antigens. In general, vaccination strategies try to mimic the invasiveness of the pathogens. DC are considered to play a central role for the provocation of primary immune responses by vaccination. A rational way of improving the potency and safety of new and already existing vaccines could therefore be to direct vaccines specifically to DC. There is a need for developing multifunctional vaccine drug delivery systems (DDS) with adjuvant effect that target DC directly and induce optimal immune responses. This paper will review the current knowledge of DC physiology as well as the progress in the field of novel vaccination strategies that directly or indirectly aim at targeting DC.

M3 - Journal article

VL - 19

SP - 229

EP - 238

JO - Pharmaceutical Research

JF - Pharmaceutical Research

SN - 0724-8741

IS - 3

ER -

ID: 47257880